VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / October 18, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)( FSE:4XT) ("XPhyto" or the "Company") is pleased to report the results of its ...
BioNxt Solutions Inc. (BioNxt), a bioscience accelerator, announced that it has executed an agreement to carry out its comparative drug absorption study for the company’s transdermal (TDS) Rotigotine ...
VANCOUVER, BC / ACCESSWIRE / February 13, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT) is pleased to report an update on its commercialization plan for its ...
The FDA has published the draft guidance for industry entitled, ‘Assessing Adhesion with Transdermal Delivery Systems and Topical Patches for ANDAs.’ This draft guidance provides updated ...
VANCOUVER, BC / ACCESSWIRE / February 13, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT) is pleased to report an update on its commercialization plan for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results